{"Compound":"alprazolam","Short.name":"Apz","Route":"po","Number.studies":8,"Total.subjects":91,"Female.subjects":18,"Age.min":18,"Age.max":48,"Median.Clearance..1.h.":4.1,"X90..CI.min":2.5,"X90..CI.max":6.72}
{"Compound":"alprazolam","Short.name":"Apz","Route":"iv","Number.studies":1,"Total.subjects":14,"Female.subjects":0,"Age.min":18,"Age.max":38,"Median.Clearance..1.h.":3.1,"X90..CI.min":2.21,"X90..CI.max":4.36}
{"Compound":"caffeine","Short.name":"Caf","Route":"po","Number.studies":5,"Total.subjects":831,"Female.subjects":435,"Age.min":20,"Age.max":68,"Median.Clearance..1.h.":4.12,"X90..CI.min":1.15,"X90..CI.max":14.8}
{"Compound":"chlorzoxazone","Short.name":"Chlr","Route":"po","Number.studies":6,"Total.subjects":132,"Female.subjects":44,"Age.min":19,"Age.max":83,"Median.Clearance..1.h.":18.4,"X90..CI.min":10.3,"X90..CI.max":32.8}
{"Compound":"clozapine","Short.name":"Clz","Route":"po","Number.studies":1,"Total.subjects":12,"Female.subjects":0,"Age.min":20,"Age.max":39,"Median.Clearance..1.h.":31.2,"X90..CI.min":15.5,"X90..CI.max":63}
{"Compound":"cyclosporine","Short.name":"Cyc","Route":"po","Number.studies":6,"Total.subjects":67,"Female.subjects":10,"Age.min":19,"Age.max":60,"Median.Clearance..1.h.":53.2,"X90..CI.min":24,"X90..CI.max":118}
{"Compound":"cyclosporine","Short.name":"Cyc","Route":"iv","Number.studies":2,"Total.subjects":21,"Female.subjects":4,"Age.min":20,"Age.max":40,"Median.Clearance..1.h.":17.5,"X90..CI.min":13.3,"X90..CI.max":22.9}
{"Compound":"dextromethorphan","Short.name":"Dex","Route":"po","Number.studies":1,"Total.subjects":22,"Female.subjects":10,"Age.min":18,"Age.max":45,"Median.Clearance..1.h.":369,"X90..CI.min":278,"X90..CI.max":490}
{"Compound":"S-mephenytoin","Short.name":"S-mph","Route":"po","Number.studies":2,"Total.subjects":14,"Female.subjects":2,"Age.min":21,"Age.max":76,"Median.Clearance..1.h.":182,"X90..CI.min":64.9,"X90..CI.max":508}
{"Compound":"midazolam","Short.name":"Mdz","Route":"po","Number.studies":2,"Total.subjects":35,"Female.subjects":10,"Age.min":24,"Age.max":44,"Median.Clearance..1.h.":68.9,"X90..CI.min":30.6,"X90..CI.max":155}
{"Compound":"midazolam","Short.name":"Mdz","Route":"iv","Number.studies":7,"Total.subjects":105,"Female.subjects":33,"Age.min":22,"Age.max":45,"Median.Clearance..1.h.":24.7,"X90..CI.min":14.1,"X90..CI.max":43.1}
{"Compound":"omeprazole","Short.name":"Omp","Route":"po","Number.studies":3,"Total.subjects":28,"Female.subjects":0,"Age.min":19,"Age.max":34,"Median.Clearance..1.h.":71.6,"X90..CI.min":26.5,"X90..CI.max":193}
{"Compound":"omeprazole","Short.name":"Omp","Route":"iv","Number.studies":3,"Total.subjects":28,"Female.subjects":0,"Age.min":19,"Age.max":34,"Median.Clearance..1.h.":31.7,"X90..CI.min":17,"X90..CI.max":58.8}
{"Compound":"sildenafil","Short.name":"Sld","Route":"po","Number.studies":2,"Total.subjects":53,"Female.subjects":0,"Age.min":19,"Age.max":81,"Median.Clearance..1.h.":62.9,"X90..CI.min":28.1,"X90..CI.max":141}
{"Compound":"tolbutamide","Short.name":"Tlb","Route":"po","Number.studies":5,"Total.subjects":39,"Female.subjects":8,"Age.min":18,"Age.max":76,"Median.Clearance..1.h.":0.86,"X90..CI.min":0.46,"X90..CI.max":1.62}
{"Compound":"tolbutamide","Short.name":"Tlb","Route":"iv","Number.studies":2,"Total.subjects":18,"Female.subjects":0,"Age.min":18,"Age.max":40,"Median.Clearance..1.h.":1.01,"X90..CI.min":0.58,"X90..CI.max":1.78}
{"Compound":"tolterodine","Short.name":"Tlt","Route":"po","Number.studies":2,"Total.subjects":15,"Female.subjects":7,"Age.min":18,"Age.max":75,"Median.Clearance..1.h.":189,"X90..CI.min":53.8,"X90..CI.max":665}
{"Compound":"tolterodine","Short.name":"Tlt","Route":"iv","Number.studies":1,"Total.subjects":8,"Female.subjects":0,"Age.min":18,"Age.max":45,"Median.Clearance..1.h.":42.2,"X90..CI.min":26.2,"X90..CI.max":67.9}
{"Compound":"triazolam","Short.name":"Trz","Route":"po","Number.studies":6,"Total.subjects":111,"Female.subjects":14,"Age.min":20,"Age.max":44,"Median.Clearance..1.h.":26.1,"X90..CI.min":11.7,"X90..CI.max":58.4}
{"Compound":"triazolam","Short.name":"Trz","Route":"iv","Number.studies":2,"Total.subjects":24,"Female.subjects":0,"Age.min":18,"Age.max":35,"Median.Clearance..1.h.":12.4,"X90..CI.min":7.27,"X90..CI.max":21.1}
{"Compound":"S-warfarin","Short.name":"S-wrf","Route":"po","Number.studies":7,"Total.subjects":84,"Female.subjects":8,"Age.min":19,"Age.max":44,"Median.Clearance..1.h.":0.24,"X90..CI.min":0.14,"X90..CI.max":0.43}
{"Compound":"S-warfarin","Short.name":"S-wrf","Route":"iv","Number.studies":1,"Total.subjects":10,"Female.subjects":0,"Age.min":18,"Age.max":66,"Median.Clearance..1.h.":0.25,"X90..CI.min":0.16,"X90..CI.max":0.38}
{"Compound":"zolpidem","Short.name":"Zlp","Route":"po","Number.studies":7,"Total.subjects":107,"Female.subjects":41,"Age.min":20,"Age.max":85,"Median.Clearance..1.h.":20.4,"X90..CI.min":7.88,"X90..CI.max":53}
{"Compound":"zolpidem","Short.name":"Zlp","Route":"iv","Number.studies":1,"Total.subjects":12,"Female.subjects":0,"Age.min":21,"Age.max":38,"Median.Clearance..1.h.":18.6,"X90..CI.min":14.6,"X90..CI.max":23.8}